CSL Behring

RIASTAP

Manufacturer:

CSL Behring

Riastap HCPCS:

J7178

HCPCS Code Descriptor:

Injection, human fibrinogen concentrate, not otherwise specified, 1 mg

Category:

J Code

Riastap NDCs:

63833-0891-51

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Riastap:

RIASTAP is a Hematology drug manufactured by CSL Behring and administered via the Intravenous route of administration. The J Code: J7178 is aligned to the drug RIASTAP.

ACCESS PRICING AND MORE BY REGISTERING

J7178 Added Date:

January 1, 2013

J7178 Effective Date:

January 1, 2019

J7178 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Riastap billing and coding information.
Riastap patient assistance information can be found through CSL Behring at the URL: https://www.cslbehring.com/patients/support-and-assistance
RIASTAP prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for RIASTAP. Please check back in a few weeks.